Skip to content

ST36 Acupoint Injection With Anisodamine for Postoperative Nausea and Vomiting

Zusanli (ST36) Acupoint Injection With Anisodamine for Postoperative Nausea and Vomiting in Women Following Bariatric Surgery: A Single-center Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05240482
Enrollment
90
Registered
2022-02-15
Start date
2022-02-20
Completion date
2022-07-06
Last updated
2022-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Nausea and Vomiting

Keywords

postoperative nausea and vomiting, bariatric surgery, Zusanli (ST36), anisodamine

Brief summary

Postoperative nausea and vomiting (PONV) is particularly distressing although it is not a fatal postoperative complication. Numbers of studies have been focused on identifying risk factors and therapies of PONV. Unfortunately, there' no consistent comments for PONV prevention in women after laparoscopic sleeve gastrectomy. Notably, Zusanli (ST36) acupoint and anisodamine have been evidenced to treat various gastrointestinal conditions. The primary outcome of this study was to evaluate the impact of anisodamine injection in ST36 on PONV in women following bariatric surgery.

Detailed description

Acupuncture has been used as a medical technique in China for at least 2,000 years. More recently, it's also been extensively used in managing headache, chronic back pain, and PONV in USA. ST36 acupuncture is reported to be an effective preventive treatment for postoperative nausea and vomiting (PONV). However, It is not clear if it could efficiently prevent PONV in female patient who has underwent bariatric surgery. At the onset of this investigation, we have already identified several methodologic issues, such as the timing of the acupuncture intervention, sample size, perioperative anesthetic techniques, and appropriate control groups. The primary outcome of this study was the total incidence of PONV during the hospital and after the discharge. Participants were randomly assigned into different groups according to the with a computer-generated randomization sequence (http://www.randomization.com). Patients, surgeons, anesthesiologists, nursing staff, and the research assistant, were all blinded to the group assignment.

Interventions

PROCEDUREST36 acupuncture

ST36 is located on the lateral surface of leg, 3 cun distal to the lower border of the patella, 1 finger-breadth lateral to the anterior crest of the tibia, between the tibialis anterior muscle and the tendon of the extensor digitorum longus. (The breadth of patient's middle finger was the proportional unit of measure the cun, defined as the distance between the two medial ends of the creases of the interphalangeal joints when the patient's middle finger is flexed).

Sponsors

The Second Hospital of Anhui Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Outcomes will be evaluated by anesthesiologists who are blinded to the treatment allocation. Patients, investigators and observers will be blinded to the patient allocation throughout the entire study period.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Female patients with an American Society of Anesthesia (ASA) physical status Ⅰ-Ⅲ 2. Scheduled for elective bariatric surgery .

Exclusion criteria

1. lack of patient consent 2. patients with contraindications for acupoint injection 3. obesity due to endocrine disorder 4. allergic diathesis for drugs used in the study 5. serious illness (heart, lung, kidney, or liver) 6. coagulation dysfunction 7. pre-existing psychological disorder 8. anticathartic , glucocorticoid or opiates medications

Design outcomes

Primary

MeasureTime frameDescription
The incidence of PONV within the first 24 hoursAt 0-24 hours after surgeryThe incidence of PONV within the first 24 hours

Secondary

MeasureTime frameDescription
Consumption of remifentanilDuring the surgeryThe consumption of remifentanil during the surgery
Consumption of cisatracuriumDuring the surgeryThe consumption of cisatracurium during the surgery
Consumption of dexmedetomidineDuring the surgeryThe consumption of cisatracurium during the surgery
Length of anesthesiaAt the end of anesthesiaFrom beginning to the end of anesthesia
Length of surgeryAt the end of surgeryFrom beginning to the end of surgery
Postoperative hospitalizationDuring hospitalDays of hospital staying after surgery
The usage of rescue antiemetic drugsWithin 24 hours after surgery in anesthesia resuscitation unitTotal usage of rescue antiemetic drugs after surgery
Adverse eventsWithin 3 months after surgeryAny adverse events after surgery within postoperative 3 months
Consumption of propofolDuring the surgeryThe consumption of propofol during the surgery
BMIBefore surgery and at the postoperative 3 monthsBody mass index
The incidence and severity of PONV assessed at 2, 6, 48, and 72 hours after surgeryAt 0-24 hours after surgeryThe incidence and severity of PONV in the anesthesia intensive care unit (AICU) or during the ward.
Early recovery outcomesBefore dischargeIncluding the time of first drink, ambulate and flatus
Time to the first rescue antiemeticsAt 0-24 hours after surgeryThe time from extubation to the first rescue antiemetics
Pittsburgh Sleep Quality IndexBefore surgery and at the postoperative 3 monthsPittsburgh Sleep Quality Index (PSQI) will be assessed the quality of sleep. The higher score means the lower quality of sleep.
Gastrointestinal Symptom Rating ScaleBefore surgery and at the postoperative 3 monthsGastrointestinal symptom rating scale (GSRS) will be used to assess gastrointestinal function. The score ranges from 0 to 45. The higher score means poorer gastrointestinal function .
Hamilton Depression Rating ScaleBefore surgery and at the postoperative 3 monthsHamilton Depression Rating Scale (HAMD) will be used to assess depression. HAMD 24 item version score range 0-96. The higher score means the higher possibility of depression.
Hamilton Anxiety Rating ScaleBefore surgery and at the postoperative 3 monthsHamilton Anxiety Rating Scale (HAM-A) will be used to assess anxiety. Total score ranges from 0 to 56, the higher the score is, the more serious the anxiety is.
QoR-15At 24 hours after surgeryQuality of Recovery-15 (QoR-15) will be used to assess quality of recovery after anesthesia. Total score ranges from 0 to 150. A higher total score means better quality of recovery.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026